Loading stock data...

SMS Lifesciences India Limited

NSE: SMSLIFE BSE: SMSLIFE

NSE
1,084.70 -18.30 (-1.66%)

Prev Close

1103

Open Price

1108.5

Volume

1,276

Today Low / High

1067 / 1126.9

52 WK Low / High

959.8 / 1749.65

Range

1,030 - 1,139

BSE
1,084.40 -15.70 (-1.43%)

Prev Close

1100.1

Open Price

1115

Volume

89

Today Low / High

1077 / 1115.5

52 WK Low / High

956.05 / 1747.85

Range

1,030 - 1,139

The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 1084.7 (target range: 1,030 - 1,139), reflecting a change of -18.3 (-1.65911%). On the BSE, it is listed at 1084.4 (target range: 1,030 - 1,139), showing a change of -15.7 (-1.42714%). The stock price is currently in decline on both exchanges, signaling a downtrend. If you're considering investing in this stock, it's important to monitor the situation closely.

08 Aug 1,130.40 0.61%
07 Aug 1,169.10 -2.82%
06 Aug 1,215.40 -4.42%
05 Aug 1,126.90 7.50%
04 Aug 1,092.60 0.43%
01 Aug 1,138.60 -4.05%
31 Jul 1,160.00 -2.35%
30 Jul 1,140.90 -0.82%
29 Jul 1,140.60 -1.46%
28 Jul 1,166.30 -2.56%
25 Jul 1,204.30 -1.40%
24 Jul 1,195.00 0.32%
23 Jul 1,235.00 -2.90%
22 Jul 1,204.90 1.93%
21 Jul 1,262.30 -5.20%

SMS Lifesciences India Limited Graph

SMS Lifesciences India Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for SMS Lifesciences India Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 1,084.70, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 1,084.40 1,095.24 985.72 - 1,204.77
1,106.09 884.87 - 1,327.31
1,116.93 781.85 - 1,452.01
Bearish Scenario 1,084.40 1,073.56 966.20 - 1,180.91
1,062.71 850.17 - 1,275.25
1,051.87 736.31 - 1,367.43

Overview of SMS Lifesciences India Limited

ISIN

INE320X01016

Industry

Biotechnology

Vol.Avg

4,077

Market Cap

3,438,387,717

Last Dividend

1.5

Official Website

Visit Website

IPO Date

2017-08-18

DCF Diff

1,913.80

DCF

-868

Financial Ratios Every Investor Needs

Stock Dividend of SMSLIFE

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2024-09-23 September 23, 24 1.5 1.5 2024-09-23 2024-10-30
2023-09-22 September 22, 23 1.5 1.5 2023-09-22 2023-10-29
2022-09-22 September 22, 22 1.5 1.5 2022-09-23 2022-10-30
2021-09-20 September 20, 21 1.5 1.5 2021-09-21 2021-10-30
2019-09-19 September 19, 19 1.5 1.5 2019-09-21 2019-10-30 2019-05-29

Stock Rating Details for SMSLIFE

Metric Value Recommendation
Overall Rating C+ Sell
DCF Score 1 Strong Sell
ROE Score 4 Buy
ROA Score 4 Buy
Debt-to-Equity (DE) Score 2 Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 344.72 Cr 294.15 Cr 50.58 Cr 0.1467 0.00 Cr 0.00 Cr 30.04 Cr 20.11 Cr 66.52 49.90 Cr 0.0583
2024-03-31 305.96 Cr 209.71 Cr 96.24 Cr 0.3146 10.55 Cr 3.39 Cr 35.95 Cr 9.09 Cr 30.08 34.94 Cr 0.0297
2023-03-31 315.56 Cr 228.00 Cr 87.56 Cr 0.2775 3.48 Cr 3.24 Cr 18.05 Cr 11.46 Cr 37.92 34.18 Cr 0.0363
2022-03-31 347.30 Cr 259.76 Cr 87.54 Cr 0.2521 2.87 Cr 2.69 Cr 24.65 Cr 25.32 Cr 83.76 48.91 Cr 0.0729
2021-03-31 257.46 Cr 187.25 Cr 70.21 Cr 0.2727 1.95 Cr 3.11 Cr 22.39 Cr 13.56 Cr 44.84 31.96 Cr 0.0527

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 1.51 Cr 389.99 Cr 177.94 Cr 196.5603 Cr 86.41 Cr 84.90 Cr 67.40 Cr 232.20 Cr 0.00 Cr 0.00 Cr 3.29 Cr 142.0676 Cr
2024-03-31 0.57 Cr 390.52 Cr 196.88 Cr 176.8142 Cr 100.72 Cr 100.15 Cr 81.21 Cr 232.02 Cr 7.30 Cr 0.00 Cr 0.00 Cr 144.5589 Cr
2023-03-31 0.15 Cr 337.39 Cr 173.36 Cr 164.0280 Cr 87.00 Cr 86.85 Cr 80.46 Cr 140.39 Cr 9.74 Cr 3.62 Cr 0.04 Cr 110.5660 Cr
2022-03-31 0.99 Cr 356.75 Cr 191.82 Cr 152.2323 Cr 79.60 Cr 78.61 Cr 84.81 Cr 193.09 Cr 14.49 Cr 43.84 Cr 0.04 Cr 135.4405 Cr
2021-03-31 8.54 Cr 302.30 Cr 173.08 Cr 129.2163 Cr 64.69 Cr 56.15 Cr 61.63 Cr 151.00 Cr 10.64 Cr 3.04 Cr 0.04 Cr 113.5996 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 29.8096 Cr -15.0607 Cr -14.8154 Cr 14.4610 Cr 0.0000 Cr 1.5081 Cr -15.3486 Cr 20.1090 Cr -13.7433 Cr -0.4535 Cr 13.8126 Cr
2024-03-31 24.3055 Cr -18.4503 Cr -6.5635 Cr 3.4378 Cr -0.7083 Cr 0.5695 Cr -20.8677 Cr 9.0928 Cr 0.1835 Cr -0.4535 Cr 5.0245 Cr
2023-03-31 0.0001 Cr -0.0003 Cr 0.0002 Cr -0.0003 Cr 0.0000 Cr 0.0000 Cr -0.0005 Cr 0.0001 Cr 17.8913 Cr -0.4535 Cr 0.0000 Cr
2022-03-31 -11.2409 Cr -7.1428 Cr 10.8335 Cr -62.3940 Cr -7.5503 Cr 0.9860 Cr -51.1531 Cr 20.0388 Cr 6.1663 Cr -0.4535 Cr -24.1950 Cr
2021-03-31 35.1698 Cr -26.2348 Cr -2.5465 Cr -0.3866 Cr 6.3885 Cr 8.5363 Cr -35.5564 Cr 19.5675 Cr 0.5091 Cr 0.0000 Cr 2.6665 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-03-31 89.11 Cr 76.59 Cr 12.53 Cr 0.1406 3.62 Cr 2.97 Cr 9.83 9.76 Cr 0.0334
2024-12-31 84.60 Cr 53.17 Cr 31.43 Cr 0.3715 9.00 Cr 5.47 Cr 18.08 12.81 Cr 0.0646
2024-09-30 78.46 Cr 50.47 Cr 27.99 Cr 0.3568 4.80 Cr 4.67 Cr 15.46 10.60 Cr 0.0596
2024-06-30 92.55 Cr 77.71 Cr 14.84 Cr 0.1603 18.52 Cr 7.00 Cr 23.15 16.28 Cr 0.0756
2024-03-31 89.99 Cr 76.64 Cr 13.36 Cr 0.1484 7.58 Cr 5.90 Cr 19.53 13.72 Cr 0.0656

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-03-31 1.51 Cr 0.00 Cr 1.51 Cr 68.79 Cr 67.40 Cr 150.57 Cr 232.20 Cr 389.99 Cr 177.94 Cr
2024-12-31 0.00 Cr 0.00 Cr 1.19 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -203.32 Cr
2024-09-30 0.27 Cr 0.92 Cr 1.19 Cr 0.00 Cr 71.09 Cr 154.70 Cr 230.03 Cr 391.40 Cr 188.09 Cr
2024-06-30 0.00 Cr 0.00 Cr 1.49 Cr 0.00 Cr 0.00 Cr 1.49 Cr 0.00 Cr 0.00 Cr -193.64 Cr
2024-03-31 1.49 Cr 0.92 Cr 1.49 Cr 51.35 Cr 81.21 Cr 155.27 Cr 229.30 Cr 390.52 Cr 196.88 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2024-12-31 5.47 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 4.67 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 7.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-03-31 5.90 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2023-12-31 4.30 Cr 7.45 Cr 0.00 Cr 0.00 Cr 7.45 Cr 9.41 Cr 1.96 Cr 0.00 Cr 7.45 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Biotechnology

Company Name Symbol Price Market Cap Volume
Biocon Limited BIOCON ₹360.25 ₹481,639,840,000.00 ₹2,377,375.00
Syngene International Limited SYNGENE ₹659.15 ₹264,559,669,880.00 ₹531,474.00
Piramal Pharma Limited PPLPHARMA ₹192.13 ₹255,388,456,666.00 ₹2,518,788.00
Concord Biotech Limited CONCORDBIO ₹1,633.60 ₹170,901,024,320.00 ₹64,779.00
Blue Jet Healthcare Limited BLUEJET ₹791.75 ₹137,341,246,285.00 ₹618,017.00
Jubilant Ingrevia Limited JUBLINGREA ₹698.20 ₹111,209,994,200.00 ₹170,522.00
Supriya Lifescience Limited SUPRIYA ₹656.00 ₹52,796,716,800.00 ₹99,003.00
Dishman Carbogen Amcis Limited DCAL ₹254.90 ₹39,963,986,700.00 ₹44,875.00
Zota Health Care Limited ZOTA ₹1,339.30 ₹39,460,465,550.00 ₹193,378.00
Panacea Biotec Limited PANACEABIO ₹430.65 ₹26,377,613,955.00 ₹150,143.00

Key Executives

MD & Executive Director
Mr. Talluri Veera Venkata Satyanarayana Murthy

Gender: male

Year Born: 1960

Whole-Time Director
Ms. Sudeepthi Gopineedi

Gender: female

Year Born: 1987

Manager of Admin/HR/IT
Mr. Vijay Babu Chirumamilla

Gender: male

Year Born:

Chief Marketing Officer & Executive Director
Mr. Talluri Venkata Praveen

Gender: male

Year Born: 1983

Chief Financial Officer & GM of Accounts / Finance
Mr. Nadella Rajendra Prasad

Gender: male

Year Born: 1957

Company Secretary & Compliance Officer
Mr. Trupti Ranjan Mohanty

Gender: male

Year Born:

General Manager of Operations
Mr. Lakshminarayana Somisetty

Gender: male

Year Born:

FAQs about SMS Lifesciences India Limited

Who is the CEO of the company?

The CEO is Talluri Veera Venkata Satyanarayana Murthy.

What is the current market price of the stock?

The current price is ₹1,137.30.

What is the 52-week price range?

The range is ₹926.6-1749.65.

What is the market capitalization of the company?

The market capitalization is ₹343.84 crores.

What is the dividend yield?

The dividend yield is 0.13%.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 17.10.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of SMS Lifesciences India Limited (ISIN: INE320X01016) is a leading Biotechnology in India. With a market capitalization of ₹343.84 crores and an average daily volume of 4,077 shares, it operates in the Biotechnology. The company last declared a dividend of ₹1.5.

Welcome to the Investing and Trading Information platform: InvesTrack.in

Note: This platform is for educational and informational purposes only. Do not consider anything as financial advice.

QUICK LINKS

Home
About us
Contact us
Privacy Policy
Disclaimer
Sitemap
Investing
Trading
Top Brokers
Tools
Live Analysis

STAY CONNECTED

Follow Us On Social Media
Get Latest Update On Social Media
Facebook Instagram Twitter

General Disclaimer: InvesTrack is an educational platform and not any type of investment advisory platform. Our Blog and videos are based on countless hours of research and experience, which you can use as a guide for your research purposes. None of our content should be considered a piece of investment advice. Earning Disclosure: InvesTrack is a community supported platform. We may earn a commission when you make a purchase through one of our links at no extra cost to you. Note: We are not SEBI Registered Advisors. This website is purely for training and educational purposes. We shall not be responsible for your profit or loss.

© Copyright 2024 - 2025 | InvesTrack